Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Parkinson disease is a common neurodegenerative disorder that leads to difficulty in effectively translating thought into action. Although it is known that dopaminergic neurons that innervate the striatum die in Parkinson disease, it is not clear how this loss leads to symptoms. Recent work has implicated striatopallidal medium spiny neurons (MSNs) in this process, but how and precisely why these neurons change is not clear. Using multiphoton imaging, we show that dopamine depletion leads to a rapid and profound loss of spines and glutamatergic synapses on striatopallidal MSNs but not on neighboring striatonigral MSNs. This loss of connectivity is triggered by a new mechanism-dysregulation of intraspine Cav1.3 L-type Ca(2+) channels. The disconnection of striatopallidal neurons from motor command structures is likely to be a key step in the emergence of pathological activity that is responsible for symptoms in Parkinson disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, rats learning new motor skills have a greater number of synapses per neuron within the motor cortex, without an increase in capillary density.96, 103, 104”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [96]
In the citing paper
“Exercise increases blood flow in the healthy brain in a wide range of animal species undergoing various exercise regimens 96, 97.”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [96]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses
Zhou, Q., Homma, K. J., & Poo, M.-M. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.011 · Cited by 1,025
Synaptic organisation of the basal ganglia
BOLAM, J. P., HANLEY, J. J., BOOTH, P. A. C., & BEVAN, M. D. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640527.x · Cited by 948
Congenital Deafness and Sinoatrial Node Dysfunction in Mice Lacking Class D L-Type Ca2+ Channels
Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S., Chen, H., Zheng, H., & Striessnig, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00013-1 · Cited by 932
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., & Greenberg, M. E. (2001) · Science · doi:10.1126/science.1063395 · Cited by 900
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same
Turrigiano, G. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01341-1 · Cited by 821
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons
Wilson, C., & Kawaguchi, Y. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02397.1996 · Cited by 795
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W.-J., & Yan, Z. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747
Self-citation
Cited by
Experience-dependent structural synaptic plasticity in the mammalian brain
Holtmaat, A., & Svoboda, K. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2699 · Cited by 1,934
Modulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718
“…is robust expression of both low threshold Cav3 and Cav1 Ca2+ channels – in addition to NMDA receptors – in SPN dendrites (Carter and Sabatini, 2004; Day et al., 2006; Carter et al., 2007), a result that has been confirmed using cell-type specific gene profiling (Day et al., 2006) (unpublished…”
InfluentialSelf-citationSynaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
“Such mice have already facilitated our understanding of the cell type-specific synaptic modifications that occur in the dorsal striatum following dopamine depletio”
BackgroundDichotomous dopaminergic control of striatal synaptic plasticity
Shen, W., Flajolet, M., Greengard, P., & Surmeier, D. J. (2008) · Science · doi:10.1126/science.1160575 · Cited by 1,190
Self-citationA translational profiling approach for the molecular characterization of CNS cell types
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suárez-Fariñas, M., Schwarz, C., Stephan, D. A., Surmeier, D. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.028 · Cited by 1,134
Self-citationSurmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203
Self-citationStriatal Plasticity and Basal Ganglia Circuit Function
Kreitzer, A. C., & Malenka, R. C. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.005 · Cited by 1,017
Cortico-Basal Ganglia Reward Network: Microcircuitry
Sesack, S. R., & Grace, A. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.93 · Cited by 985
“…dendrites provides a potential substrate for enabling local plasticity of glutamate transmission based on synaptic experience (Flores et al, 2005; Day et al, 2006; Surmeier et al, 2007) or chronic exposure to psychostimulants that enhance DA levels (Robinson and Kolb, 2004; Wolf et al, 2004; Lee…”
Self-citationGong, S., Doughty, M., Harbaugh, C. R., Cummins, A., Hatten, M. E., Heintz, N., & Gerfen, C. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2707-07.2007 · Cited by 977
“These BAC-EGFP transgenic lines provide a valuable resource by enabling specific neurons types to be identified (for example, in neurophysiologic studies) (Day et al., 2006).”
BackgroundCortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852
Self-citationDo thin spines learn to be mushroom spines that remember?
Bourne, J., & Harris, K. M. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.009 · Cited by 843
Direct and indirect pathways of basal ganglia: a critical reappraisal
Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Di Filippo, M. (2014) · Nature Neuroscience · doi:10.1038/nn.3743 · Cited by 828
Corticostriatal connectivity and its role in disease
Shepherd, G. M. G. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3469 · Cited by 824
Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798
Dopaminergic modulation of synaptic transmission in cortex and striatum
Tritsch, N. X., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.023 · Cited by 756
“…NMDA receptors and low-threshold Ca V 3 channels, which are enriched in distal dendrites and spines (Carter and Sabatini, 2004; Carter et al., 2007; Day et al., 2006), but it is currently unclear whether the D1 receptorevoked enhancement is mediated by direct modulation of NMDA receptors or…”
BackgroundBertran-Gonzalez, J., Bosch, C., Maroteaux, M., Matamales, M., Hervé, D., Valjent, E., & Girault, J.-A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1039-08.2008 · Cited by 619
“…a dramatic segregation between the two populations of MSNs is in agreement with recent electrophysiological findings, which revealed that striatopallidal MSNs display several forms of plasticity that are absent in striatonigral MSNs (Day et al., 2006; Kreitzer and Malenka, 2007; Shen et al., 2007).”
ResultSchulz-Schaeffer, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0711-0 · Cited by 627
“It has been shown in brain slice preparations of C57/Bl6 mice that the depletion of the neurotransmitter dopamine leads to profound loss of dendritic spines [26].”
BackgroundPathophysiology of Parkinsonism
Galvan, A., & Wichmann, T. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.017 · Cited by 549
“However, more recent studies using transgenic mice in which the cellular expression of green fluorescent protein (GFP) is driven by the D1- or by the D2-receptor promoter showed that GFP-expressing striatal neurons from D1-GFP mice express exclusively the mRNA for the D1 receptor, while GFP-expressing neurons in D2-GF…”
BackgroundInfluentialOlanow, C. W., Obeso, J. A., & Stocchi, F. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70521-x · Cited by 547
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
“, 2008), and a likely protective action of L-DOPA therapy on the striatopallidal pathway (Day et al., 2006).”
Physiology and pharmacology of striatal neurons
Kreitzer, A. C. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135422 · Cited by 530
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
“Administration of the monoamine depletor reserpine or of 6-OHDA leads to spine loss and to alterations in corticostriatal connectivity that are limited to the medium spiny neurons of the indirect output pathwa”
BackgroundHIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R., Langford, D., & Masliah, E. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2040 · Cited by 517
“Recently, in vitro techniques have been developed to portray synaptodendritic damage dynamicall”
BackgroundThe 6-Hydroxydopamine model of parkinson’s disease
Simola, N., Morelli, M., & Carta, A. R. (2007) · Neurotoxicity Research · doi:10.1007/bf03033565 · Cited by 514
“…several studies have reported a decrease in glutamatergic synapses in the ipsilateral striatum of rats unilaterally injected with 6-OHDA, particularly of those located in striatopallidal neurons, whereas synapses on striatonigral neurons seem to be spared (Ingham et al., 1998; Day et al., 2006).”
Wang, Z., Kai, L., Day, M., Ronesi, J., Yin, H. H., Ding, J., Tkatch, T., Lovinger, D. M., & Surmeier, D. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.010 · Cited by 514
“Whole-cell voltage-clamp or current-clamp recordings were performed using standard techniques (Choi and Lovinger, 1997; Day et al., 2005 ).”
BackgroundMethodSelf-citationAbnormal oscillatory synchronisation in the motor system leads to impaired movement
Brown, P. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.12.001 · Cited by 479
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
“hat was reported previously (Day et al., 2006), Fieblinger et al.”
Dichotomous Anatomical Properties of Adult Striatal Medium Spiny Neurons
Gertler, T. S., Chan, C. S., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2660-08.2008 · Cited by 471
“…chromosome (BAC) transgenic mice expressing enhanced green fluorescent protein (eGFP) under the control of promoters for the D1 and D2 receptors has eliminated this problem (Day et al., 2006; Wang et al., 2006; Kreitzer and Malenka, 2007; Shen et al., 2007; Ade et al., 2008; Cepeda et al., 2008).”
BackgroundSelf-citationInfluence of Phasic and Tonic Dopamine Release on Receptor Activation
Dreyer, J. K., Herrik, K. F., Berg, R. W., & Hounsgaard, J. D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1894-10.2010 · Cited by 423
“However, the pathways activated in postsynaptic striatal medium spiny neurons (MSNs) are complex (Fernandez et al., 2006; Surmeier et al., 2007), and the postsynaptic effect of dopamine may deviate from the prediction of Equation 12.”
BackgroundAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
“To balance early changes in inhibitory dopaminergic tonus, compensatory mechanisms, such as plastic adaptations in the cortico-striatal pathway [208–210], probably delaymotor impairment and justify the existence of a pre-symptomatic period [211] preceding the gradual appearance of symptoms.”
BackgroundDopamine Receptor Activation Is Required for Corticostriatal Spike-Timing-Dependent Plasticity
Pawlak, V., & Kerr, J. N. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4402-07.2008 · Cited by 412
“…clear that dopamine receptor activation plays a central role in corticostriatal plasticity, whether structural plasticity (Ingham et al., 1989; Day et al., 2006; Gerfen, 2006) or synaptic plasticity induced using high-frequency afferent stimulation (HFS) (Calabresi et al., 1992b; Wickens et…”
BackgroundTaverna, S., Ilijic, E., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5493-07.2008 · Cited by 399
Self-citationMentis, G. Z., Blivis, D., Liu, W., Drobac, E., Crowder, M. E., Kong, L., Alvarez, F. J., Sumner, C. J., & O'Donovan, M. J. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.032 · Cited by 381
“In neurodegenerative diseases, abnormalities of synaptic connectivity are thought to account for early clinical deficits (Day et al., 2006; Shankar et al., 2008).”
BackgroundThe basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359
Early microglia activation in a mouse model of chronic glaucoma
Bosco, A., Steele, M. R., & Vetter, M. L. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22516 · Cited by 350
Fieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 295
Self-citationCorticostriatal and Thalamostriatal Synapses Have Distinctive Properties
Ding, J., Peterson, J. D., & Surmeier, D. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0435-08.2008 · Cited by 291
“which D1 or D2 receptor-expressing MSNs were labeled with GFP (Heintz, 2001; Day et al., 2006).”
BackgroundMethodInfluentialSelf-citationShen, W., Tian, X., Day, M., Ulrich, S., Tkatch, T., Nathanson, N. M., & Surmeier, D. J. (2007) · Nature Neuroscience · doi:10.1038/nn1972 · Cited by 292
Self-citationSynaptic Dysfunction in Parkinson’s Disease
Picconi, B., Piccoli, G., & Calabresi, P. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_24 · Cited by 290
“…the dopaminergic nigrostriatal terminals, as observed in advanced PD, is associated to maladaptive plasticity (Calabresi et al. 2007), alteration of striatal dendritic spines (Anglade et al. 1996; Day et al. 2006), and changes of glutamatergic signaling (Betarbet et al. 2000; Picconi et al. 2004).”
Costa, R. M., Lin, S.-C., Sotnikova, T. D., Cyr, M., Gainetdinov, R. R., Caron, M. G., & Nicolelis, M. A. L. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.030 · Cited by 284
“For example, the development of dopaminergic neurotoxic lesions is accompanied by changes in the expression of glutamatergic receptors (Kaneda et al., 2005), and repeated DA depletion can be accompanied by the loss of glutamatergic synapses in striatopallidal neurons (Day et al., 2006).”
BackgroundAcetylcholine–dopamine balance hypothesis in the striatum: An update
Aosaki, T., Miura, M., Suzuki, T., Nishimura, K., & Masuda, M. (2010) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2010.00588.x · Cited by 274
IκB Kinase Regulates Social Defeat Stress-Induced Synaptic and Behavioral Plasticity
Christoffel, D. J., Golden, S. A., Dumitriu, D., Robison, A. J., Janssen, W. G., Ahn, H. F., Krishnan, V., Reyes, C. M., Han, M.-H., Ables, J. L., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4763-10.2011 · Cited by 267
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors
Higley, M. J., & Sabatini, B. L. (2010) · Nature Neuroscience · doi:10.1038/nn.2592 · Cited by 268
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia
Cenci, M. A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.005 · Cited by 265
Blesa, J., Trigo-Damas, I., Dileone, M., del Rey, N. L.-G., Hernandez, L. F., & Obeso, J. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.002 · Cited by 256
Timing is not everything: neuromodulation opens the STDP gate
Pawlak, V. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00146 · Cited by 255
Seven problems on the basal ganglia
Nambu, A. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.11.001 · Cited by 253
The thalamostriatal system in normal and diseased states
Smith, Y., Galvan, A., Ellender, T. J., Doig, N., Villalba, R. M., Huerta-Ocampo, I., Wichmann, T., & Bolam, J. P. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00005 · Cited by 247
“…of dendritic spines of striatal MSNs in PD patients (Stephens et al., 2005; Zaja-Milatovic et al., 2005), rodent models of PD (Ingham et al., 1989; Day et al., 2006; Kusnoor et al., 2009) and in MPTP-treated monkeys (Raju et al., 2008; Smith et al., 2009; Villalba et al., 2009, 2013; Villalba and…”
BackgroundHood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., Stewart, J., & Amir, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2128-10.2010 · Cited by 246
“Glutamate plays a key role in clock gene expression in the SCN (Reppert and Weaver, 2001) and after 6-OHDA lesions of DA inputs to the striatum there are changes in both glutamate release and responsiveness of D2 DA receptor-bearing striatopallidal neurons to glutamate (Day et al., 2006).”
BackgroundDifferential Excitability and Modulation of Striatal Medium Spiny Neuron Dendrites
Day, M., Wokosin, D., Plotkin, J. L., Tian, X., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1840-08.2008 · Cited by 243
“Adaptations in MSN connectivity and dendritic architecture in PD models are dependent on the loss of DA and the consequent rise in ACh signaling through broadly expressed M1 muscarinic receptors (Day et al., 2006; Shen et al., 2007).”
BackgroundMethodInfluentialSelf-citationLooking BAC at striatal signaling: cell-specific analysis in new transgenic mice
Valjent, E., Bertran-Gonzalez, J., Hervé, D., Fisone, G., & Girault, J.-A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.005 · Cited by 241
Shuen, J. A., Chen, M., Gloss, B., & Calakos, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5492-07.2008 · Cited by 242
“…differences in both intrinsic synaptic properties and disease involvement between MSNs in the two pathways, highlighting the importance of studying MSNs with reference to their pathway (Day et al., 2006; Kreitzer and Malenka, 2007; Shen et al., 2007; Surmeier et al., 2007; Ade et al., 2008).”
BackgroundAlterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state
Galvan, A., Devergnas, A., & Wichmann, T. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00005 · Cited by 244
BDNF signaling and survival of striatal neurons
Baydyuk, M., & Xu, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00254 · Cited by 245
“These distinct expression patterns in the MSNs of the two pathways are further confirmed in bacterial artificial chromosome (BAC) transgenic mice expressing fluorescent proteins under the control of the promoter for either DRD1a or DRD2 (Day et al., 2006; Shuen et al., 2008).”
BackgroundOxidative damage and neurodegeneration in manganese-induced neurotoxicity
Milatovic, D., Zaja-Milatovic, S., Gupta, R. C., Yu, Y., & Aschner, M. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.004 · Cited by 241
“MSN have radially projecting dendrites that are densely studded with spines, synapsing with dopamine and glutamate axons and providing the site of integration of several key inputs and outputs of the striatum (Day et al., 2006).”
BackgroundResultCell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2153 · Cited by 233
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1408 · Cited by 232
“In fact, the intake of caffeine is inversely correlated with the incidence of Parkinson’s disease in different cohorts [111–115], and A2A receptor antagonists (or A2A receptor gene deletion) attenuate motor impairment in different animal models of Parkinson’s disease [116–118].”
BackgroundInfluentialHallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., & Dunah, A. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0792-06.2006 · Cited by 225
“1 B, C, available at www.jneurosci.org as supplemental material), as noted by others (Day et al., 2006; Falk et al., 2006).”
BackgroundRole of astrocyte–synapse interactions in CNS disorders
Blanco‐Suárez, E., Caldwell, A. L. M., & Allen, N. J. (2017) · The Journal of Physiology · doi:10.1113/jp270988 · Cited by 222
“Consequently there is a significant decrease in dendritic spine density on neurons in the striatum (Day et al., 2006; Morales et al., 2015).”
BackgroundAdvances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Brichta, L., Greengard, P., & Flajolet, M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.003 · Cited by 223
Calcium Signaling in Dendrites and Spines: Practical and Functional Considerations
Higley, M. J., & Sabatini, B. L. (2008) · Neuron · doi:10.1016/j.neuron.2008.08.020 · Cited by 217
“Interestingly, electron microscopy has demonstrated that L-type channels in MSN spines consist of the a1D subunit-containing CaV 1.3 subtype (Day et al., 2006).”
InfluentialGagnon, D., Petryszyn, S., Sanchez, M. G., Bories, C., Beaulieu, J. M., De Koninck, Y., Parent, A., & Parent, M. (2017) · Scientific Reports · doi:10.1038/srep41432 · Cited by 210
Kramer, E. R., Aron, L., Ramakers, G. M. J., Seitz, S., Zhuang, X., Beyer, K., Smidt, M. P., & Klein, R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050039 · Cited by 209
“There is evidence that loss of DA neurons in the basal ganglia or dopamine depletion can lead to changes in the striatum, such as loss of spines and glutamatergic synapses [42] and may eventually lead to cell death [43].”
BackgroundAdenosine, adenosine A2A antagonists, and Parkinson's disease
Jenner, P., Mori, A., Hauser, R., Morelli, M., Fredholm, B. B., & Chen, J. F. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.12.006 · Cited by 199
“Morphological changes are correlated to altered electrophysiological activity underlining the potential importance of A2A receptors in the control of neuronal changes associated with dopamine neuron degeneration in the indirect pathway [37].”
BackgroundCepeda, C., André, V. M., Yamazaki, I., Wu, N., Kleiman‐Weiner, M., & Levine, M. S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06038.x · Cited by 198
“Together, these data demonstrate significant differences in electrophysiological properties of subpopulations of MSSNs defined by selective expression of D1 and D2 receptors.”
BackgroundMethodResultInfluentialMilestones in research on the pathophysiology of Parkinson's disease
Wichmann, T., DeLong, M. R., Guridi, J., & Obeso, J. A. (2011) · Movement Disorders · doi:10.1002/mds.23695 · Cited by 197
Smith, Y., & Villalba, R. (2008) · Movement Disorders · doi:10.1002/mds.22027 · Cited by 186
Ade, K. K., Wan, Y., Chen, M., Gloss, B., & Calakos, N. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00032 · Cited by 176
“…widely to reveal phenotypic differences between these two classes of MSNs as well as evidence for subtype-selective impairment in disease states (Day et al., 2006, 2008; Kreitzer and Malenka, 2007; Shen et al., 2007, 2008; Ade et al., 2008; Cepeda et al., 2008; Gertler et al., 2008; Janssen et…”
Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection
Surmeier, D. J., Plotkin, J., & Shen, W. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.10.003 · Cited by 179
Self-citationSuárez, L. M., Solís, O., Caramés, J. M., Taravini, I. R., Solís, J. M., Murer, M. G., & Moratalla, R. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.006 · Cited by 179
CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels
Pinggera, A., Lieb, A., Benedetti, B., Lampert, M., Monteleone, S., Liedl, K. R., Tuluc, P., & Striessnig, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.020 · Cited by 180
Rapid Target-Specific Remodeling of Fast-Spiking Inhibitory Circuits after Loss of Dopamine
Gittis, A. H., Hang, G. B., LaDow, E. S., Shoenfeld, L. R., Atallah, B. V., Finkbeiner, S., & Kreitzer, A. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.035 · Cited by 177
“, 2000), accompanied by reduced spine density (Day et al., 2006) and collaterals between both MSN subtypes (Taverna et al.”
Lunardi, N., Ori, C., Erisir, A., & Jevtovic-Todorovic, V. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9088-z · Cited by 176
“Selective synapse loss and neuronal loss have been reported in pathological conditions such as chronic degenerative diseases (Day et al. 2006; Lacor et al. 2004) and ischemic and reperfusion injuries (Garcia et al.”
What is the degree of segregation between striatonigral and striatopallidal projections?
Bertran-Gonzalez, J. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00136 · Cited by 173
“The importance of afferent fibers is well illustrated by the fact that, in cultured striatal neurons, the emergence of spontaneous and evoked excitatory synaptic currents as well as dendritic spines depends on the presence of excitatory afferents (Segal et al., 2003; Day et al., 2006).”
BackgroundStriatal synapses, circuits, and Parkinson's disease
Zhai, S., Tanimura, A., Graves, S. M., Shen, W., & Surmeier, D. J. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.08.004 · Cited by 174
Self-citationVučcković, M. G., Li, Q., Fisher, B., Nacca, A., Leahy, R. M., Walsh, J. P., Mukherjee, J., Williams, C., Jakowec, M. W., & Petzinger, G. M. (2010) · Movement Disorders · doi:10.1002/mds.23407 · Cited by 174
Synaptic pathology: A shared mechanism in neurological disease
Henstridge, C. M., Pickett, E., & Spires-Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 174
“stage features of many neurological conditions such as Alzheimer’s disease [3], Motor Neuron disease [4, 5], Huntington’s disease [6], Parkinson’s disease [7, 8] and multiple sclerosis [9].”
Rylander, D., Recchia, A., Mela, F., Dekundy, A., Danysz, W., & Cenci, M. A. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150425 · Cited by 172
“Dysregulation of L-type calcium channels in striatal neurons is linked to atrophy of dendritic spines and loss of corticostriatal synapses (Day et al., 2006).”
BackgroundDopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
Villalba, R. M., Lee, H., & Smith, Y. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.025 · Cited by 171
“These findings were supported by quantitative immunoelectron microscopy data from 6-OHDA-treated adult rats showing a significant decrease in the number of striatal D1-negative spines (Day et al., 2006).”
BackgroundResultInfluentialSensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
Glajch, K. E., Fleming, S. M., Surmeier, D. J., & Osten, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.007 · Cited by 168
Self-citationDifferential Tonic GABA Conductances in Striatal Medium Spiny Neurons
Ade, K. K., Janssen, M. J., Ortinski, P. I., & Vicini, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3908-07.2008 · Cited by 167
“It has been suggested that dendritic excitatory synaptic currents in MSNs likely go undetected in whole-cell recordings when potassium-based internal solutions are used because of leak K currents between the synapse and the soma (Day et al., 2006).”
BackgroundResultPaillé, V., Picconi, B., Bagetta, V., Ghiglieri, V., Sgobio, C., Di Filippo, M., Viscomi, M. T., Giampà, C., Fusco, F. R., Gardoni, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2149-10.2010 · Cited by 170
“A complete DA denervation, as observed in advanced PD, induces maladaptive plasticity (Calabresi et al., 2007), alteration of striatal dendritic spines (Anglade et al., 1996; Day et al., 2006), and changes of glutamatergic signaling (Betarbet et al., 2004; Picconi et al., 2004).”
BackgroundToy, W. A., Petzinger, G. M., Leyshon, B. J., Akopian, G. K., Walsh, J. P., Hoffman, M. V., Vučković, M. G., & Jakowec, M. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.017 · Cited by 169
“Other receptors that are known to be modulate spine loss in the context of DA-depletion, such as the L-type calcium channel may play a role in exercise mediated effects on spine density (Day et al., 2006).”
BackgroundResultInfluentialMean-field modeling of the basal ganglia-thalamocortical system. I
van Albada, S. J., & Robinson, P. A. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.12.018 · Cited by 168
“In a study of mouse brain slices, Day et al. (2006) found that lack of dopamine causes a profound loss of dendritic spines on striatopallidal neurons but not on striatonigral neurons.”
BackgroundHIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R., Langford, D., Masliah, E., Grant, I., Heaton, R., Wong, J., Smith, D., Letendre, S., & McCutchan, A. (2008) · BMC Proceedings · doi:10.1186/1753-6561-2-s1-s13 · Cited by 167
Downregulation of NR3A-Containing NMDARs Is Required for Synapse Maturation and Memory Consolidation
Roberts, A. C., Díez-García, J., Rodriguiz, R. M., López, I. P., Luján, R., Martínez-Turrillas, R., Picó, E., Henson, M. A., Bernardo, D. R., Jarrett, T. M., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.016 · Cited by 166
“…of synapses because of its ability to mediate tonic, noncoincident calcium entry, one of the signals thought to contribute to synaptic pruning (Day et al., 2006), or through the recruitment via its intracellular domains (with limited homology to NR1 and NR2 subunits) of signaling complexes or…”
Lin, L., Lesnick, T. G., Maraganore, D. M., & Isacson, O. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.006 · Cited by 164
Fitting, S., Ignatowska-Jankowska, B. M., Bull, C., Skoff, R. P., Lichtman, A. H., Wise, L. E., Fox, M. A., Su, J., Medina, A. E., Krahe, T. E., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.026 · Cited by 162
“A similar gradual decline in function, accompanied by diminishing connectivity, is seen in a variety of progressive degenerative diseases, including Alzheimer’s disease (10) and Parkinson’s disease (11).”
BackgroundSynaptic dysfunction in Parkinson's disease
Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 160
Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease
Fuxe, K., Marcellino, D., Genedani, S., & Agnati, L. (2007) · Movement Disorders · doi:10.1002/mds.21440 · Cited by 160
Avila, I., Parr‐Brownlie, L. C., Brazhnik, E. S., Castañeda, E., Bergstrom, D. A., & Walters, J. R. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.016 · Cited by 154
“, 2001b) and/or the loss of glutamatergic synapses (Day et al., 2006), providing increased transmission of cortical oscillations to downstream basal ganglia nuclei.”
BackgroundDopaminergic modulation of striatal networks in health and Parkinson's disease
Surmeier, D. J., Graves, S. M., & Shen, W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.008 · Cited by 174
Self-citationDendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
“Aberrant spine morphology also occurs in psychiatric disorders [13] and drug addiction [14], as well as in neurodegenerative disorders, including Alzheimer’s disease (AD) [15], Huntington’s disease (HD) [16] and Parkinson’s disease [ 17 ].”
Wichmann, T., & DeLong, M. R. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0426-6 · Cited by 181
Synaptically driven state transitions in distal dendrites of striatal spiny neurons
Plotkin, J. L., Day, M., & Surmeier, D. J. (2011) · Nature Neuroscience · doi:10.1038/nn.2848 · Cited by 169
Self-citationExtrastriatal dopaminergic circuits of the basal ganglia
Rommelfanger, K. S., & Wichmann, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00139 · Cited by 182
Muscarinic modulation of striatal function and circuitry
Goldberg, J. A., Ding, J. B., & Surmeier, D. J. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23274-9_10 · Cited by 150
Self-citationNeuronal death: where does the end begin?
Conforti, L., Adalbert, R., & Coleman, M. P. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.02.004 · Cited by 174
Rodríguez‐Gómez, J. A., Lu, J., Velasco, I., Rivera, S. N., Zoghbi, S. S., Liow, J., Musachio, J. L., Chin, F. T., Toyama, H., Seidel, J., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0386 · Cited by 148
“Recent work shows that DA denervation leads to rapid changes in spine density in striatopallidal medium spiny neurons [ 77 ].”
BackgroundMottahedin, A., Ardalan, M., Chumak, T., Riebe, I., Ek, C. J., & Mallard, C. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00190 · Cited by 169
“…in Cellular Neuroscience | www.frontiersin.org 9 July 2017 | Volume 11 | Article 190 advanced PD, the denervation of the dopaminergic nigrostriatal terminals is associated with perturbed synapse plasticity and alteration of striatal dendritic spines (Anglade et al., 1996; Day et al., 2006).”
Background
Metadata
- Authors
- Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., Mugnaini, E., Deutch, A. Y., Sesack, S. R., Arbuthnott, G. W., & Surmeier, D. J.
- Affiliations
- Northwestern University (US)
- University of Pittsburgh (US)
- University of Edinburgh (GB)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Surmeier, D James
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-01-15
- Volume
- 9
- Issue
- 2
- Pages
- 251-259
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2127235616
- Semantic Scholar
- f5053a014f262e9d424b82f7536ce2f320899a27
- Cited by
- 745
- References
- 52
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 22 · 2020: 29 · 2019: 31 · 2018: 31 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 38 · 2013: 35 · 2012: 39
- FWCI
- 41.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health (5p01ns044282-05)
- National Institute of Neurological Disorders and Stroke (NS 19608, NS 34696, NS 44282, NS047085, P50NS047085)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, striatopallidal neurons, medium spiny neurons, glutamatergic synapses, dendritic spine loss, dopamine depletion, striatonigral neurons, Cav1.3 L-type calcium channel, motor command, striatum
- MeSH terms
- Animals, Corpus Striatum, Disease Models, Animal, Glutamine, Mice, Inbred C57BL, Neural Pathways, Organ Culture Techniques, Parkinson Disease, Synapses, Microscopy, Immunoelectron, Patch-Clamp Techniques, Reverse Transcriptase Polymerase Chain Reaction, Calcium Channels, L-Type, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.